Glucagon-Like Peptide-1 Promotes Islet Cell Growth and Inhibits Apoptosis in Zucker Diabetic Rats
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
A constant remodeling of islet cell mass mediated by proliferative and apoptotic stimuli ensures a dynamic response to a changing demand for insulin. In this study, we investigated the effect of glucagon-like peptide-1 (GLP-1) in Zucker diabetic rats, an animal model in which the onset of diabetes occurs when the proliferative potential and the rate of β-cell apoptosis no longer compensate for the increased demand for insulin. We subjected diabetic rats to a 2-d infusion of GLP-1 and tested their response to an ip glucose tolerance test. GLP-1 produced a significant increase of insulin secretion, which was paralleled by a decrease in plasma glucose levels (P < 0.001 and P < 0.01, respectively). Four days after the removal of the infusion pumps, rats were killed and the pancreas harvested to study the mechanism by which GLP-1 ameliorated glucose tolerance. Ex vivo immunostaining with the marker of cell proliferation, Ki-67, showed that the metabolic changes observed in rats treated with GLP-1 were associated with an increase in cell proliferation of the endocrine and exocrine component of the pancreas. Terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling staining, a marker of cellular apoptosis, indicated a reduction of apoptotic cells within the islet as well in the exocrine pancreas in GLP-1-treated rats. Double immunostaining for the apoptotic marker caspase-3 and for insulin showed a significant reduction of caspase-3 expression and an increase in insulin content in GLP-1-treated animals. Finally, staining of pancreatic sections with the nuclear dye 4,6-Diaminidino-2-phenyl-dihydrochloride demonstrated a marked reduction of fragmented nuclei in the islet cells of rats treated with GLP-1. Our findings provide evidence that the beneficial effects of GLP-1 in Zucker diabetic rats is mediated by an increase in islet cell proliferation and a decrease of cellular apoptosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies to date that have reported an increase in β-cell mass with glucagon-like peptide 1 (GLP-1)-1 based therapies were undertaken in young rodents (17–21).”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [17]
Citations
Cites
Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Nauck, M. A., Kleine, N., �rskov, C., Holst, J. J., Willms, B., & Creutzfeldt, W. (1993) · Diabetologia · doi:10.1007/bf00401145 · Cited by 1,092
Thorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Vilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
FEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
Perfetti, R. (2000) · Endocrinology · doi:10.1210/en.141.12.4600 · Cited by 442
Self-citationApoptosis Participates in the Remodeling of the Endocrine Pancreas in the Neonatal Rat
Scaglia, L. (1997) · Endocrinology · doi:10.1210/en.138.4.1736 · Cited by 418
β-Cell Mass Dynamics in Zucker Diabetic Fatty Rats
Finegood, D. T., McArthur, M. D., Kojwang, D., Thomas, M. J., Topp, B. G., Leonard, T., & Buckingham, R. E. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1021 · Cited by 374
Research works printed but not linked: 2
- Nauck, 1993, Normalization of fasting hyperglycemia by exogenous glucagon-like peptide-1 [7–36 amide] in type 2 (non-insulin dependent) diabetic patients, Diabetologia, 36, 741, 10.1007/BF00401145 · DOI · Paper page
- Weibel, 1978, Stereologic methods. In: Practical methods for biologic morphometry, London: Academic Press; vol, 1, 101
Cited by
Items 401–500 of 505
Incretin physiology and its role in type 2 diabetes mellitus.
Svec, F. (2010) · PubMed · Cited by 6
Chae, H. Y., Lee, M., Hwang, H. J., Kim, H. A., Kang, J. G., Kim, C. S., Lee, S. J., & Ihm, S. (2013) · Transplant International · doi:10.1111/tri.12052 · Cited by 4
Torun, A. N., & Ertuğrul, D. T. (2015) · InTech eBooks · doi:10.5772/59241 · Cited by 4
“Regeneration of β-cells is maintained by stimulation of βcell proliferation and differentiation of ductal epithelial progenitor cells into β-cells by GLP-1 [40-44].”
BackgroundMulherin, A. J., Oh, A., Kim, H., Grieco, A., Lauffer, L., & Brubaker, P. (2011) · Obesity and metabolism · doi:10.14341/2071-8713-5305 · Cited by 4
Incretins and Regulation of Insulin Secretion
Nauck, M. A., & Meier, J. J. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_17 · Cited by 4
Xiong, G.-X., Xiong, L., & Li, X. (2016) · Laser Physics · doi:10.1088/1054-660x/26/9/095605 · Cited by 4
Gao, H., Song, Z., Zhao, Q., Wu, Y., Tang, S., Alahdal, M., Shen, Y., Xing, Y., Pan, Y., Li, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491978 · Cited by 5
Tip 2 diabetes mellitus tedavisinde inkretinler
Çolak, R. (2012) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm.omu.29.s1.007 · Cited by 4
Next-Generation GLP-1 Therapy: An Introduction to Liraglutide
Repas, T. B. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2480 · Cited by 4
“reversibly bind to albumin, and to resist DPP-4 degradation, resulting in a half-life of approximately 13 hours.(5,6) These properties make liraglutide suitable for once-daily dosing.”
BackgroundGastrointestinal Peptide Hormones Regulating Energy and Glucose Homeostasis
Drucker, D. J. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50009-x · Cited by 5
Role of the Sweet Taste Receptor in Glucose Metabolism: No Sweets for Diabetes?
Nomura, M., & Kawahara, Y. (2015) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.14-00250-1 · Cited by 4
Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes
Hanley, S. C. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v12i2.267 · Cited by 5
Microencapsulation of Pancreatic Islets : A Non-Vascularised Transplantation Model
Bohman, S. (2008) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 3
Gao, H., Zhao, Q., Li, K., Qin, F., Yin, X., Lu, Z., Song, Z., Wu, Y., Shen, Y., Pan, Y., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112454 · Cited by 3
Levine, J. A., Kaihara, K. A., Layden, B. T., & Wicksteed, B. L. (2016) · Islets · doi:10.1080/19382014.2016.1198457 · Cited by 3
Castro, M. C., Villagarcía, H. G., Schinella, G. R., Massa, M. L., & Francini, F. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159363 · Cited by 4
Li, X., Zhang, X., Xie, X., Dong, T., Lv, C., Guan, R., Zhang, W., Ji, G., Chen, F., Wang, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111476 · Cited by 3
“GLP-1, as an incretin hormone, can enhance glucose-dependent insulin release from pancreatic β -cells, delay gastric emptying, inhibit glucagon secretion, and promote β -cell proliferation [18,19].”
BackgroundThe Role of Incretins in Insulin Secretion
Schroeder, B. E., & Kolterman, O. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_4 · Cited by 3
Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome
Wiedeman, P. E., & Trevillyan, J. M. (2005) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2005.05.020 · Cited by 4
Influence of Hydrophobic Ion Pairing on Formulation Performance of Liraglutide in PLGA Microspheres
Vitore, J. G., Yalamanda, V., Tomar, D. S., Rojekar, S. V., Rana, D., & Benival, D. M. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03195-4 · Cited by 2
“In animal studies, native GLP-1 shows beneficial effects by promoting beta cell proliferation and inhibiting apoptosis in vitro [10, 11].”
Incretin Therapy and Beta Cell Function
Goundan, P. N., UNDERWOOD, P. C., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.006 · Cited by 2
Preservation of b-cell function by targeting b-cell mass
de Koning, E. J. P., Bonner‐Weir, S., & Rabelink, T. J. (2008) · Cited by 2
Insulin-Producing Cells Derived from Embryonic Stem Cells: A Potential Treatment for Diabetes
Weir, G. C., Haagensen, A. L., & Bonner‐Weir, S. (2004) · Elsevier eBooks · doi:10.1016/b978-012436643-5/50080-8 · Cited by 2
Bariatric surgery: a cure for diabetes?
Taheri, S., Tahrani, A. A., & Barnett, A. H. (2009) · Practical Diabetes · doi:10.1002/pdi.1418 · Cited by 2
Zhao, X., Tang, Y. G., Wu, S.-Z., Wang, C., Perfetti, R., Khoury, N., Cai, D.-H., He, F., Su, X., Go, V. L. W., et al. (2012) · ISRN Endocrinology · doi:10.5402/2012/608672 · Cited by 4
“International Scholarly Research Network ISRN Endocrinology Volume 2012, Article ID 608672, 11 pages doi:10.5402/2012/608672”
BackgroundSelf-citationThe Mechanisms of Action for Treatments of Type 2 Diabetes
Leahy, J. L. (2007) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707302886 · Cited by 2
Organic consequences of ileal transposition in rats with diet-induced obesityPreprint
Azevedo, J. L., Lourenço, P., de Miguel, G., Carlini, M., Lapchick, V., de Azevedo, O. C., Azevedo, O., Leal, L., Azevedo, J. L., Aguiar-Yamaguchi, G., et al. (2011) · Nature Precedings · doi:10.1038/npre.2011.6122.1 · Cited by 1
Valdez, C. A. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.7.650 · Cited by 2
Seo, D. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.85.2017.tde-23032017-153731 · Cited by 2
Jetton, T. L., Gupta, D., & Peshavaria, M. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-256-8_3 · Cited by 1
Ketotic Hypoglycaemia Following Sleeve Gastrectomy
He, J., Phillips, L. K., Nisbet, J. C., & Morton, A. (2025) · Clinical Endocrinology · doi:10.1111/cen.15232 · Cited by 1
“GLP1 promotes pancreatic islet cell growth and prevents islet cell apoptosis [14], while administration of the GLP1 antagonist exendin (9 ‐ 39) is able to prevent postprandial hypoglycaemia [15].”
Molecular Biology of Gluco-Incretin Function
Klinger, S., & Thorens, B. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_16 · Cited by 1
Incretins: new targets for the prevention of diabetes and obesity
Neff, K., & le Roux, C. W. (2013) · Clinical Lipidology · doi:10.2217/clp.12.80 · Cited by 1
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2014) · Springer eBooks · doi:10.1007/978-3-319-09915-6_21 · Cited by 1
Vildagliptin improves glycemic control in type 2 diabetes patients undergoing hemodialysis
Ishioka, K., Furuya, R., Iwagami, M., Tsutsumi, D., Mochida, Y., Oka, M., Maesato, K., Moriya, H., Ohtake, T., Hidaka, S., et al. (2013) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.46.103 · Cited by 1
Incretin-Based Therapies: Revisiting Their Mode of Action
Layden, B. T., Wicksteed, B. L., & Mauvais‐Jarvis, F. (2017) · Endocrinology · doi:10.1210/en.2017-00252 · Cited by 1
“Along with this, both GLP1R mimetics and DPP4 inhibitors have been suggested to enhance b-cell proliferation and limit b-cell apoptosis, thus expanding b-cell mass (5, 6).”
BackgroundAhn, S. M., & Hyung, W. J. (2021) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2021.100.4.218 · Cited by 1
“[23] reported these budding appearances in a 12-week-old ZDF rat.”
BackgroundKeshishian, A., Malgorzata, R., & Miguel, R. (2021) · doi:10.36959/608/451 · Cited by 2
The Mechanisms of Action for Treatments of Type 2 Diabetes
Leahy, J. (2007) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721707302s886 · Cited by 1
Calnuc‐derived nesfatin‐1‐like peptide is an activator of tumor cell proliferation and migration
Vignesh, R., & Aradhyam, G. K. (2023) · FEBS Letters · doi:10.1002/1873-3468.14712 · Cited by 1
TİP 2 DİYABET VE İNKRETİNLERİN ETKİSİ
Gök, H. (2023) · Atlas Universitesi Tip ve Saglik Bilimleri Dergisi · doi:10.54270/atljm.2023.35 · Cited by 3
Effects of MGB on Type 2 Diabetes in Morbid Obesity, and Comparison with Other Operations
Forieg, A. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-76177-0_13 · Cited by 1
Incretin physiology in health and disease
Meier, J. J., & Nauck, M. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch11 · Cited by 1
Pancreas Biology, Pathology, and Tissue Engineering
Macfarlane, W. M., Bone, A. J., & Harrison, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-74660-9_8 · Cited by 2
The role of glucagon-like peptide-1 on food intake, glucokinase expression and fatty acid metabolism
Zhang, H. (2009) · Louisiana State University · doi:10.31390/gradschool_theses.3765 · Cited by 1
Kheder, M. H. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.122879 · Cited by 1
Tratamento do Diabetes Mellitus
Rosa, R. R. P. A. (2022) · Revista Saúde em Foco · doi:10.12819/rsf.2022.9.1.5 · Cited by 3
Mostafa, N. M. E.-S. B. E.-D. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Ruokahalun säätely ja lihavuuden lääkehoito : lihavuuslääkkeiden tehoseulontamenetelmä seeprakalalla
Heine, S. (2014) · Helda - University of Helsinki Institutional Repository
Mulder, D. J., Heerspink, H. J. L., & Lefrandt, J. D. (2012) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-012-0002-6
„Glucagon-like peptide-1“-basierende Therapie: Neues aus der Grundlagenforschung
Ritzel, R. A. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0698-8
Insulin Resistance, Diabetes and its Complications
Ng, D. S. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400011
MicroRNA-mediated regulation of Cadm1 contributes to beta cell function and energy homeostasis
Rathjen, T. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-6345
Liraglutide: A Review of its Use in the Treatment of Diabetes Mellitus
Nicolucci, A., & Rossi, M. C. (2010) · Clinical Medicine Reviews in Vascular Health · doi:10.4137/cmrvh.s1652
Yook, S., Jeong, J., & Byun, Y. (2014) · Macromolecular Research · doi:10.1007/s13233-014-2120-z
Isolated ileal interposition in enteroendocrine L cells differentiationPreprint
Azevedo, J.-L., Neves, K., Azevedo, J., Bernardes, L., de Azevedo, O. C., Aguiar-Yamaguchi, G., Miguel, G. P. S., Cardia, W., Marigliani, B., Azevedo, J.-L., et al. (2011) · Nature Precedings · doi:10.1038/npre.2011.6614.2
“are reduced peripheral insulin resistance, decreased apoptosis of pancreatic beta cells, increased differentiation of primitive pancreatic canaliculus cells into adult beta cells, and increased proliferation of beta cells.(86,87)”
BackgroundWnt signaling, a novel pathway for coronary artery disease and metabolic syndrome
Mani, A. (2007) · International Cardivascular Research Journal
Structural changes in intestinal enteroendocrine cells after ileal interposition in normal ratsPreprint
Azevedo, J.-L., Hirata, A. E., Rocha, R., Leal, L. P. F. F., Borborema, J., Marigliani, B., Azevedo, J.-L., Bernardes, L., de Azevedo, O. C., Miguel, G. P. S., et al. (2011) · Nature Precedings · doi:10.1038/npre.2011.6683.1
“The most remarkable effects of GLP-1 are reduced peripheral insulin resistance, decreased apoptosis of pancreatic beta cells, increased differentiation of primitive pancreatic canaliculus cells into adult beta cells, and increased proliferation of beta cells.(86,87) N at ur e P re ce di ng s : d oi :1 0.”
Backgroundβ-Zell-Erhalt durch inkretinbasierte Therapien: Fiktion oder Wirklichkeit?
Menge, B. (2011) · Der Diabetologe · doi:10.1007/s11428-011-0700-5
Andréasson, S. (2015) · Epsilon Archive for Student Projects (Swedish University of Agricultural Sciences)
INCRETIN-BASED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES
Ionescu-Tirgoviste, C., Davila, C., & Miulescu, R. D. (2010)
The effects of DPP-4 inhibitors on vascular endothelial function in diabetes
Salheen, S. M. (2015) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27591369
Farah, L. X. S. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-05102015-114814
Widenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
“Activating GLP-1R signalling has been shown in several rodent models of diabetes to improve β-cell mass by increasing β-cell proliferation and decreasing β-cell apoptosis (Farilla et al., 2002; Li et al., 2003; Wang and Brubaker, 2002; Xu et al., 1999).”
BackgroundNess-Abramof, R. (2009) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(09)79359-x
2) Treatment Strategies for Preventing Atherosclerosis in Patients with Diabetes Mellitus.
Kadowaki, T. (2010) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.99.447
Casiraghi, F. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/casiraghi-francesca_phd2014-03-11
“Antidiabetogenic effect of glucagonlike peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.”
BackgroundGerő, L. (2016) · Orvosi Hetilap · doi:10.1556/650.2016.30440
Paulo, S., & Girardi, C. (2015)
Glucagon like peptide-1 (glp-1) in myocardial ischaemia-reperfusion injury.
Bose, A. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique)
Treatment Patterns in Youth with Diabetes
Chiu, H., & Pihoker, C. (2008) · CRC Press eBooks · doi:10.3109/9781420047981-20
Metabolic Syndrome and the Liver
Yoshiji, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55790-6_8
“GLP-1, a prominent active compound of the incretin family, is a gut-derived peptide secreted in a nutrient-dependent manner from the small intestine and stimulates glucosedependent insulin production and secretion via specific receptors expressed on the islet β cells [201–204].”
BackgroundParacrine regulation of glucagon secretion from pancreatic islets
Elliott, A. D. (2014)
The Acute Regulation of Intestinal Chylomicron Secretion by Glucagon-like Peptides
Hsieh, J. (2012) · TSpace (University of Toronto)
Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
Flock, G. B. (2012) · TSpace (University of Toronto)
de Sousa, L. R., Filho, A. A. R., Azevedo, Í. M., Carvalho, M. D. F., & Cunha, A. (2011)
Bilasy, S. E. (2014) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2014.6955
“In previous studies done on animal models, GLP-1 and GIP have been reported to have positive effects on β-cell mass through promoting β-cell survival or stimulating islet neogenesis (Farilla et al., 2002; Tourrel et al., 2002; Trumper et al.,2002).”
ResultAntidiabetic properties of centella asiatica in type II diabetic rats.
Oyenihi, A. B. (2016) · ResearchSpace (University of KwaZulu-Natal)
Insight in disease and drug interactions, with treatment optimisation of patients with cancer
Knapen (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190510lk
Type 2 diabetes mellitus and gastrointestinal cancer: Disease, drugs, or distortion?
de Jong (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190605rj
“In contrast, lower risks of various GI cancers have been observed when comparing the use of insulin glargine to the use of non‐glargine insulin.(44,45) Yet, important limitations have been noted for observational studies on the risk of cancer with the use of insulin, such as marked heterogeneity between studies, limit…”
BackgroundGlucagon‐Like Peptide‐1 Receptor Activators
Wagner, M., Evers, A., Bossart, M., & Konkar, A. A. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc268
Papulonodular Lesions in a Patient of Diabetes Mellitus Receiving Sitagliptin and Metformin
Agrawal, P. K., Gautam, A., Pursnani, N., Farooqui, M., & Kalra, S. K. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_270_21
“[1] Farilla et al. 2002 and Li et al. 2003 have corroborated that DPP‑4 inhibitors increase islet cell proliferation, and decrease cell apoptosis in vitro.”
BackgroundInfluentialNeue Ansätze zur Regeneration der insulinproduzierenden β-Zelle
Schlüssel, E., & Lickert, H. (2022) · Die Diabetologie · doi:10.1007/s11428-022-00945-x
Pascutti, P. F. G., Lorenzo, V. T. D., Oliveira, S. D. A., Oliveira, P. R. P. F. D., Oliveira, I. C. F. D., Pizzolatto, C. A., Machado, N. T. D. C., Rocha, Y. L. N., Batista, A. C. R. D. C., Eismann, F. C. P., et al. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-058
Deletion of RalGAP β protects pancreatic β cells and improves glycemic control
Feng, W., Zhu, S., Kong, L., Zhang, W., Liu, F., Jin, Y., Yu, T., Chen, X., Meng, Z., Chen, Q., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70133 · Cited by 2
“It has been shown that liraglutide can enhance postprandial insulin secretion, 57 increase β cell proliferation, 58 and inhibit β cell apoptosis.”
Ханенко, О., & Попович, Ю. І. (2025) · Bulletin of Problems Biology and Medicine · doi:10.29254/2523-4110-2025-4-179/addition-72-74
Inflammation intestinale et diabète de type 2 : effet du Resveratrol
Dao, T. M. A. (2011) · theses.fr (ABES) · doi:10.70675/ba3c8576z889ez4199zb7d6z98de312b9efb
Watanuki, K., Akiyama, R., Watanabe, S., Adachi, E., & Shimada, M. (2026) · Nutrients · doi:10.3390/nu18071155
“…the proliferation of β -cells and suppresses their apoptosis through mechanisms mediated by the PDX-1 and PI3K/Akt signaling pathways [47,85–87]. α -Glucosidase in the brush border of the small intestine acts as a carbohydrate hydrolase on the terminal bonds of starch and glycogen to…”
As, A., Балыкова, Л. А., Zaslavskaya, K. Y., Shohin, I. E., Геннадьевна, Б. Т., Zorina, L. A., Shcherbakova, V. S., Куркин, Д. В., Koryanova, K. N., Mishchenko, E. S., et al. (2026) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2026-14-4-387-409
Kim, T., Seo, J., Kang, S., Kim, H. K., Lee, B., Lee, J., & Go, G. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02259-w
G-protein-coupled receptors (GPCRs) in the treatment of diabetes
Abirami, P. M., & Ramkumar, K. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33887-8.00018-0
Beyond Postprandial Symptoms: Fasting Hypoglycemia in Post-Bariatric Hypoglycemia
Lin, J., Shams, A., & Lawler, H. M. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.09.119
Metadata
- Authors
- Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R.
- Affiliations
- Cedars-Sinai Medical Center (US)
- University of California, Los Angeles (US)
- Corresponding author
- Perfetti, Riccardo
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2002-11-01
- Volume
- 143
- Issue
- 11
- Pages
- 4397-4408
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2063693981
- Cited by
- 502
- References
- 20
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 17 · 2020: 12 · 2019: 18 · 2018: 12 · 2017: 16 · 2016: 18 · 2015: 25 · 2014: 32 · 2013: 33 · 2012: 33
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Federation for Aging Research
- Cedars-Sinai Medical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- glucagon-like peptide-1, islet cell proliferation, beta-cell apoptosis, type 2 diabetes, insulin secretion, glucose tolerance, caspase-3, Ki-67, exocrine pancreas, pancreatic islets, nuclear fragmentation
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Cell Division, Diabetes Mellitus, Glucagon, Insulin, Islets of Langerhans, Kinetics, Male, Peptide Fragments, Protein Precursors, Rats, Zucker, Apoptosis, Ki-67 Antigen, Caspases, In Situ Nick-End Labeling, Rats, Glucagon-Like Peptide 1, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.